NCT02733341View on ClinicalTrials.gov

The Effect of IV Cangrelor and Oral Ticagrelor Study

PHASE4CompletedINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

July 21, 2016

Primary Completion Date

October 1, 2018

Study Completion Date

October 1, 2018

Conditions

Acute Coronary Syndrome (ACS)High On-treatment Platelet Reactivity (HTPR)Microvascular Obstruction (MVO)ST-segment Elevation Myocardial Infarction (STEMI)Thrombolysis in Myocardial Infarction (TIMI)Unstable Angina (UA)

Interventions

DRUG

Cangrelor

DRUG

Ticagrelor

Trial Locations (1)

WV10 0QP

The Royal Wolverhampton NHS Trust, Wolverhampton

All Listed Sponsors

lead

The Royal Wolverhampton Hospitals NHS Trust

OTHER_GOV

NCT02733341 - The Effect of IV Cangrelor and Oral Ticagrelor Study | Biotech Hunter | Biotech Hunter